Sumitomo Pharma Switzerland GmbH
Registry sponsor category
Industry
- Company name
- Sumitomo Pharma Switzerland GmbH
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Sumitomo Pharma Switzerland
- Sumitomo Pharma Switzerland GmbH
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (17)
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
- Congenital Athymia Patient Registry
- Expanded Access Protocol Thymus Transplantation
- Farber Disease Natural History Study
- MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
- Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
- Parathyroid and Thymus Transplantation in DiGeorge #931
- Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation
- Phase I/II Thymus Transplantation With Immunosuppression #950
- Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
- Serum-Free Thymus Transplantation in DiGeorge Anomaly
- Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
- The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
- Thymus Transplantation Dose in DiGeorge #932
- Thymus Transplantation in DiGeorge Syndrome #668
- Thymus Transplantation Safety-Efficacy
- Thymus Transplantation With Immunosuppression